By David W. Vincent B.Sc., MPH, Ph.D.

Introduction

The pharmaceutical and biotechnology industries are highly regulated sectors that require strict adherence to cleaning and sanitization protocols to ensure product quality, safety, and compliance with regulatory requirements. Routine monitoring of cleaning processes is essential to verify the effectiveness of cleaning procedures and prevent contamination that could compromise the quality and safety of pharmaceutical products and biotechnological materials. Implementing routine cleaning process monitoring program is a requirement per Stage 3 of the FDA continued Process Verification: Ongoing assurance is gained during routine production that the process remains in a state of control. Reference Figure 1. In this article, we will explore the importance of routine monitoring of cleaning processes in pharmaceutical and biotechnology manufacturing facilities, including sampling locations on equipment product contact surfaces, types of sampling methods, types of testing, frequency of sampling, trends of results, how often to sample, evaluation of results, using Artificial Intelligent (AI)Technology and corrective actions when results exceed limits.

There are three stages in the process validation lifecycle (process design, process qualification, and continued process verification) [1]. The first stage, process design, is challenging for pharmaceutical and biopharmaceutical firms to plan and execute on time.

Figure 1: Life Cycle Approach: FDA Guidance’s Process Validation: General Principles and Practices

This is a three-part article, Part 1 we discuss Cleaning Validation Optimization A Case Study

Part 2 we will discuss Establishing a Routine Monitoring Program for Cleaning Processes and Part 3 we will discuss how to perform a Routine Monitoring Program for Cleaning Processes trending of data and how to identify abnormal trends and what corrective actions need to be implemented.

In pharmaceutical and biotechnology manufacturing facilities, sampling locations on equipment product contact surfaces are critical for monitoring the cleanliness and effectiveness of cleaning procedures. Product contact surfaces, such as mixing tanks, filling equipment, and packaging machinery, are areas where microbial contamination can occur and pose a risk to product quality and safety. Sampling locations should be strategically chosen to represent the area most susceptible to contamination (worst case sample sites – based on riboflavin and development studies) and where residues of cleaning agents or microbial contaminants are likely to accumulate. Common sampling locations on equipment product contact surfaces include:

Mixing tanks
Process vessels i.e. Chemical Reactors, Bioreactors
Skids Chromatography, Ultrafiltration, etc.
Assemble components
Filling nozzles and valves
Pipelines and tubing
Filters and filter housings
Tablet presses and capsule filling machines
Packaging equipment surfaces
Cleanroom equipment surfaces

Understanding the Cleaning Validation Process

The cleaning validation process consists of several key steps:

Cleaning Procedure Development: This step involves developing and validating a cleaning procedure that removes residues from equipment surfaces. Factors such as the type of equipment, cleaning agent, cleaning method, and cleaning time worst case sampling locations are considered during procedure development.
Cleaning Validation: Once the cleaning procedure is established, cleaning validation is performed to demonstrate that the procedure consistently removes residues to a predetermined acceptable level. Typically, this involves sampling surfaces, analyzing samples for residue levels, and comparing the results to the acceptable limits.
Routine Monitoring and Optimization: After the cleaning procedure is validated, routine monitoring and optimization are performed to ensure that the procedure remains effective over time and identify improvement opportunities.

Importance of Routine Monitoring and Optimization

Routine monitoring of the cleaning validation process are important for several reasons:

Compliance: Regulatory agencies such as the FDA require pharmaceutical manufacturers to have a robust cleaning validation program. Routine monitoring ensures ongoing compliance with these requirements.
Product Quality: Effective cleaning validation is essential to prevent cross-contamination between products, which could lead to quality issues or safety concerns.
Operational Efficiency: Optimizing the cleaning validation process can lead to shorter cleaning times, reduced resource consumption, and increased productivity.

Key Elements of Routine Monitoring and Optimization

Sampling and Testing: Routine sampling and testing of equipment surfaces are essential to ensure effective cleaning procedures. Sampling methods should be scientifically justified, and testing should be performed using validated analytical methods.
Data Analysis: Data from routine monitoring should be analyzed to identify trends or patterns indicating a need for process improvement. Statistical tools such as trend analysis and control charts can be used.
Continuous Improvement: Continuous improvement is a key routine monitoring and optimization aspect. Feedback from monitoring activities should be used to identify areas for improvement in cleaning procedures or equipment design.
Documentation and Reporting: Documentation of routine monitoring activities and any changes made to the cleaning validation process is essential for regulatory compliance. Reports should be clear and concise and include justification for any changes made.

Type of Sampling Methods

Several sampling methods can be used to monitor the cleanliness of equipment product contact surfaces in pharmaceutical and biotechnology manufacturing facilities. The selection of sampling methods depends on the type of surface to be sampled, the nature of the contaminant of interest, and the sensitivity of the analytical method used to detect contaminants. These sample sites should have been identified during development studies and confirmed at the time of the cleaning validation studies. Common sampling methods used in pharmaceutical and biotechnology cleaning processes include:

Swab sampling involves using a sterile swab moistened with a suitable solvent or buffer to collect residues from equipment surfaces. Swabs are then transferred to a sample container for microbiological or chemical testing analysis.
Rinse sampling involves rinsing equipment surfaces with a known volume of a suitable solvent or buffer to collect residues. The rinse solution is then collected in a sample container for microbiological or chemical testing analysis.
Surface sampling involves directly sampling equipment surfaces using a sterile sampling tool, such as a contact plate or a membrane filter. The sampled surface area is then transferred to a suitable medium for analysis by microbiological or chemical testing methods.
Visual Inspections: After completion of the cleaning process, rigorous visible inspection of equipment surfaces is conducted to meticulously scrutinize for any residual substances, particles, or contaminants that could compromise product quality or safety. This inspection ensures that all surfaces are visually clean and meet predefined acceptance criteria, thereby affirming the effectiveness of the cleaning procedures in maintaining stringent hygiene standards.
Air sampling is used to monitor the presence of airborne contaminants, such as microbial particles or particulate matter, in pharmaceutical and biotechnology manufacturing facilities. Air samplers collect air samples onto agar plates, filters, or other collection media for analysis. It is important to consider that external environmental factors can impact the clean equipment during hold time. The area where process equipment is cleaned should be monitored routinely.
Adenosine triphosphate (ATP) bioluminescence testing is a rapid method for assessing the cleanliness of surfaces based on the detection of ATP, a marker for organic residues. ATP bioluminescence testing provides real-time results and can be used to quickly assess cleaning procedures’ effectiveness.
Microbiological testing involves the enumeration and identifying microbial contaminants on equipment product contact surfaces using traditional culture-based methods or rapid microbial detection systems. Microbiological testing helps to assess the microbial load on surfaces and detect potential contamination risks.
Endotoxin sampling for cleaning validation involves a specific approach to ensure that equipment and surfaces are adequately cleaned to prevent contamination. Endotoxins are a type of pyrogenic substance found in the cell walls of gram-negative bacteria that can cause fever and other immune responses in humans. Use validated methods for sampling endotoxins, which may involve swabbing, rinsing, or wiping surfaces with appropriate solvents or buffers that can recover endotoxins effectively.

Frequency of Sampling

The sampling frequency for routine monitoring of cleaning processes in pharmaceutical and biotechnology manufacturing facilities should be based on risk assessments, cleaning schedules, and product requirements, and regulatory guidelines. Typically, sampling frequencies are determined by factors such as the type of product being manufactured, the complexity of the manufacturing process, the level of contamination risk, and the effectiveness of cleaning procedures.

In general, routine monitoring of cleaning processes involves regular sampling of equipment product contact surfaces before and after cleaning procedures. The sampling frequency may vary depending on the criticality of the equipment, the nature of the products being manufactured, and the level of contamination risk associated with the process.

For example, high-risk areas or critical equipment that come into direct contact with the product may require more frequent sampling to ensure the effectiveness of cleaning procedures and minimize the risk of contamination. On the other hand, lower-risk areas or less critical equipment may require less frequent sampling.

It is important to establish a sampling plan that considers these factors and ensures sampling is conducted at appropriate intervals to comprehensively assess cleaning effectiveness. The routine monitoring results should be documented and reviewed regularly to identify trends, evaluate the performance of cleaning procedures, and make any necessary adjustments to the cleaning program.

Overall, routine monitoring of cleaning processes is essential to ensure the cleanliness and compliance of equipment product contact surfaces in pharmaceutical and biotechnology manufacturing facilities. By implementing a robust sampling plan and using appropriate testing methods, companies can effectively monitor and maintain the cleanliness of their manufacturing environments to produce high-quality products and comply with regulatory requirements.

In addition to routine monitoring of cleaning processes, pharmaceutical and biotechnology manufacturing facilities must have a comprehensive cleaning validation program in place. Cleaning validation is critical to ensuring the effectiveness of cleaning procedures and demonstrating compliance with regulatory requirements.

Cleaning validation involves a series of studies and tests to confirm that the cleaning procedures can consistently remove residues and contaminants from equipment product contact surfaces to predetermined cleanliness levels. This includes evaluating the cleaning process parameters, such as cleaning agents, cleaning methods, contact time, and rinsing procedures.

Key elements of a cleaning validation program include:

Cleaning validation protocol: A cleaning validation protocol outlines the specific procedures and acceptance criteria for validating the cleaning process. It includes details on the equipment to be cleaned, sampling locations, sampling methods, testing methods, acceptance criteria, and validation schedule.
Cleaning validation studies: Cleaning validation studies involve conducting cleaning trials to evaluate the effectiveness of the cleaning process based on data from cleaning development studies. This may include visual inspection, swab sampling, rinse sampling, and residue testing to verify the removal of residues and contaminants.
Analytical methods: Analytical methods used for cleaning validation should be sensitive, specific, and validated for their intended use. These methods may include microbiological testing, chemical analysis, ATP bioluminescence testing, or other suitable techniques for detecting residues and contaminants.
Documentation and reporting: All cleaning validation activities should be thoroughly documented, including protocols, study reports, test results, and deviations or corrective actions. This documentation records the cleaning validation process and demonstrates compliance with regulatory requirements.
Ongoing monitoring and revalidation: After initial cleaning validation, ongoing monitoring and periodic revalidation are necessary to ensure the continued effectiveness of the cleaning process. This may involve routine sampling, trend analysis, and periodic revalidation studies to confirm that the cleaning procedures remain effective over time.

Use of Digital Artificial Intelligent (AI) Software Programs

Cleaning validation digital AI software programs are revolutionizing the pharmaceutical and biotechnology industry by enhancing the efficiency and accuracy of routine monitoring processes. These advanced programs utilize AI algorithms to streamline swabbing, rinse sampling, and visual inspection activities, allowing for real-time data collection and analysis. By automating data acquisition and interpretation, these software solutions enable pharmaceutical and biomanufacturer’s companies to generate comprehensive trending data swiftly and reliably. This capability not only ensures compliance with stringent regulatory requirements but also facilitates initiative-taking decision-making in maintaining cleanliness standards and optimizing cleaning procedures. The integration of AI-driven software in cleaning validation not only enhances operational efficiency but also strengthens overall quality control measures in pharmaceutical/biotechnology manufacturing.

These innovative tools leverage artificial intelligence to automate and optimize the entire process of swabbing, rinse sampling, and visual inspection. AI algorithms embedded within the software streamline data collection from these activities, ensuring real-time monitoring and analysis. This capability enables pharmaceutical /biomanufacturers to not only detect potential contaminants promptly but also to identify trends in cleanliness performance over time. By continuously gathering and analyzing data, these programs provide valuable insights into the effectiveness of cleaning procedures and equipment, facilitating initiative-taking adjustments and improvements. Moreover, the integration of AI-driven software ensures consistency in compliance with regulatory requirements, mitigating risks associated with product quality and patient safety.

Additionally, cleaning validation digital AI software programs play a crucial role in incorporating risk assessment methodologies to establish scientifically sound acceptance criteria for cleanliness standards. These programs utilize AI algorithms to analyze data collected from swabbing, rinse sampling, and visual inspections in real-time. By integrating risk assessment tools, such as failure mode effects analysis (FMEA) or hazard analysis critical control points (HACCP), the software can identify critical parameters and potential risks associated with cleaning processes. This systematic approach helps pharmaceutical companies determine whether acceptance criteria have been met by evaluating the probability of contaminants remaining after cleaning and the severity of their impact on product quality and patient safety.

Furthermore, the software’s ability to trend data over time allows for proactive identification of deviations and adjustments to cleaning procedures, ensuring continuous improvement in cleanliness standards. By leveraging AI-driven risk assessment within cleaning validation, pharmaceutical/biotechnology manufacturers enhance their ability to maintain consistent and compliant operations while minimizing risks related to product contamination.Top of Form

Bottom of Form

Challenges and Best Practices

Complexity of Equipment: Pharmaceutical equipment can be complex, with many surfaces that must be cleaned. Proper cleaning validation requires understanding the equipment’s design and how residues may accumulate on its surfaces.
Analytical Methods: Analyzing residues on equipment surfaces can be challenging due to the low residues involved and the need for sensitive analytical methods. It is important to validate analytical methods for their intended use in cleaning validation.
Cross-Contamination Risk: Cross-contamination between products must be carefully managed, especially in facilities where multiple products are manufactured. Proper cleaning procedures and monitoring are essential to mitigate this risk.
Training and Education: Proper training of personnel involved in the cleaning validation process is crucial to ensure that procedures are followed correctly, and that data is interpreted accurately.
Regular Audits and Inspections: Regular audits and inspections by regulatory agencies or internal quality teams can help identify areas for improvement in the cleaning validation process.
Implementation Cleaning Process Digital AI Software Program: Implementing a digital AI software program for cleaning processes offers the advantages of enhanced efficiency through automation, real-time monitoring capabilities to ensure compliance with cleaning protocols, and data-driven insights for continuous process improvement. However, challenges may include initial setup costs, the need for staff training to effectively utilize the software and ensuring compatibility with existing systems and regulatory requirements. Careful planning and adaptation can maximize the benefits while mitigating potential drawbacks in integrating AI into cleaning validation procedures.

Conclusion

By implementing a robust cleaning validation program in addition to routine monitoring of cleaning processes, pharmaceutical, and biotechnology manufacturing facilities can ensure the cleanliness of equipment product contact surfaces, minimize the risk of contamination, and maintain compliance with regulatory requirements. Cleaning validation is an essential component of Good Manufacturing Practices (GMP) and is critical for ensuring the quality and safety of pharmaceutical and biotechnology products. Overall, the adoption of cleaning validation digital AI software programs marks a transformative shift towards precision and efficiency in pharmaceutical manufacturing processes.

References

FDA. (2011). Guidance for Industry: Process Validation: General Principles and Practices. Retrieved from https://www.fda.gov/media/71021/download
PDA. (2018). Technical Report No. 49: Points to Consider for Cleaning Validation. Retrieved from https://www.pda.org/-/media/pda/documents/public/pda_technical_reports/tr49-2018_cleaningvalidation.pdf
ISPE. (2016). ISPE Baseline® Guide: Pharmaceutical Engineering Guide for New and Renovated Facilities: Cleaning Validation Systems. Retrieved from https://ispe.org/publications/guidance-documents/pharmaceutical-engineering-guide-new-renovated-facilities-cleaning-validation-systems
WHO. (2017). WHO Expert Committee on Specifications for Pharmaceutical Preparations: Annex 5: Good Manufacturing Practices for Pharmaceutical Products: Main Principles. Retrieved from https://apps.who.int/iris/bitstream/handle/10665/325722/WHO-TRS-1010-eng.pdf
Pharmaceutical Online (April 2018). Measuring Risk In Cleaning: Cleaning FMEAs And The Cleaning Risk Dashboard. By Andrew Walsh; Thomas Altmann; Alfredo Canhoto, Ph.D.; Ester Lovsin Barle, Ph.D.; David G. Dolan, Ph.D.; Andreas Flueckiger, M.D.; Igor Gorsky; Jessica Graham, Ph.D.; Robert Kowal; Mariann Neverovitch; Mohammad Ovais; Osamu Shirokizawa; and Kelly Waldron, Ph.D. Received from Measuring Risk In Cleaning Cleaning FMEAs And The Cleaning Risk Dashboard (pharmaceuticalonline.com)